Molecule AG

Are students really learning or just passing classes? Juan Keymer explains why teaching across generations isn’t as simple as it sounds. Watch the full episode: https://lnkd.in/dv5jsmgG

Germany’s National Academy of Sciences just said it out loud: aging should be a medical target. Longevity science is no longer niche. The world is finally catching up. Because why wait to treat age-related diseases, when we can treat aging itself? https://lnkd.in/eC7XBxJQ

NFTs started with hype but evolved into serious tools. At DeSci Berlin, Kevin Noessler broke down how Molecule uses NFTs to bring intellectual property onchain; turning IP into something verifiable, transferable, and ready for a decentralized future.

How would you design a better system for funding science? At DeSci Berlin, Prof. Ed Boyden from Massachusetts Institute of Technology shared 3 key principles: trust great ideas, leave room for the unexpected, and connect discovery to real-world impact. That’s exactly what DeSci is building toward.

Ready to surf through psychedelic knowledge graphs? To make learning an adventure? That’s what the $BeeARD token is all about. And, as announced today via Molecule Labs - PsyDAO is joining the party. GraphSurfer is like an interactive map for scientific research built by BeeARD. People can explore knowledge graphs that show how ideas and studies connect. Learning becomes fun, as it was always meant to be. - Navigate to Molecule's home page using the link in our bio - Click on the $BeeARD token page - View the update under the 'Project Progress' section To learn more: https://lnkd.in/dq34W4P5

DeSci Berlin 2025 was our most packed DeSci Berlin yet, with 350+ in person attendees and 50.000 live-streamers. The ecosystem showed up, and showed out: DeSci is scaling fast! Missed it? Full recap is live: https://lnkd.in/d_ebZwaP

A fresh science update for the longevity maxis! VitaRNA, one of the key aging projects in the DeSci ecosystem, has teamed up with Syenex - a company that specializes in getting genetic drugs into the right cells, safely and precisely. Why is this news?  Precision delivery is the bottleneck for genetic medicines. No matter how perfect your drug is, if you can't get it to the right place, it won't matter.  That's why Michael Torres, VitaDAO, and the $VITARNA token holders are partnering with experts in the field as they tackle age-related diseases. You can see the full update on our site; - Navigate to Molecule's home page using the link in our bio - Click on the $VITARNA token page - View full report under the 'Project Progress' section Find the full update here: https://lnkd.in/d97SCjEk

"TradSci builds first, finds the market later. We flip that." At DeSci Berlin, Morgan Richards shared how designing biotech from day one with scalability and industrial application in mind can avoid dead ends and can unlock faster paths to real-world impact.

Science didn’t start centralized, and it doesn’t have to stay that way. At DeSci Berlin, Theodor Beutel called DAOs a new kind of institutional tech: built for local autonomy, transparent incentives, and scientific systems that serve the people doing the work.

Research in Science and specially Mental Health should be more accesible! Stumbled across Molecule AG recently—and I haven’t stopped thinking about it. In a world where life science innovation often stalls behind institutional silos and funding bottlenecks, Molecule offers a new path: a decentralized platform for biotech IP and collaborative research. This isn’t just another tool—it’s a shift in mindset. A vision where researchers, funders, and communities co-own and co-drive breakthroughs. 🔍 What stood out to me: The open, modular approach to scientific IP How they’re empowering new actors—DAOs, patient groups, DeSci communities—to shape research priorities A belief that science should be both rigorous and accessible I’ll be watching this space closely ;)